169 related articles for article (PubMed ID: 26220797)
1. The DNA index as a prognostic tool in hilar cholangiocarcinoma.
Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D
J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797
[TBL] [Abstract][Full Text] [Related]
2. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
3. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
[TBL] [Abstract][Full Text] [Related]
4. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
[TBL] [Abstract][Full Text] [Related]
5. DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance.
Abou-Rebyeh H; Al-Abadi H; Jonas S; Rotter I; Bechstein WO; Neuhaus P
Cancer Detect Prev; 2002; 26(4):313-9. PubMed ID: 12430636
[TBL] [Abstract][Full Text] [Related]
6. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
7. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
8. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
[TBL] [Abstract][Full Text] [Related]
9. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
13. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
[TBL] [Abstract][Full Text] [Related]
14. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.
Zheng-Rong L; Hai-Bo Y; Xin C; Chuan-Xin W; Zuo-Jin L; Bing T; Jian-Ping G; Sheng-Wei L
Am Surg; 2011 May; 77(5):627-33. PubMed ID: 21679599
[TBL] [Abstract][Full Text] [Related]
15. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma.
Kiriyama M; Ebata T; Aoba T; Kaneoka Y; Arai T; Shimizu Y; Nagino M;
Br J Surg; 2015 Mar; 102(4):399-406. PubMed ID: 25611179
[TBL] [Abstract][Full Text] [Related]
17. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
[TBL] [Abstract][Full Text] [Related]
18. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma.
Xiong J; Nunes QM; Huang W; Wei A; Ke N; Mai G; Liu X; Hu W
J Surg Res; 2015 Mar; 194(1):194-201. PubMed ID: 25454973
[TBL] [Abstract][Full Text] [Related]
19. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
